Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glycemic Control for Diabetes Mellitus”

233 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 233 results

Not applicableStudy completedNCT02846779
What this trial is testing

Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes

Who this might be right for
Diabetes
Brigham and Women's Hospital 6,000
Large-scale testing (Phase 3)Study completedNCT00754988
What this trial is testing

Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 666
Post-approval studies (Phase 4)Looking for participantsNCT03463564
What this trial is testing

Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients

Who this might be right for
Type 1 Diabetes Mellitus
University of Campania Luigi Vanvitelli 150
Not applicableNot Yet RecruitingNCT07151833
What this trial is testing

GlucoBites Cookies (Gynura Procumbens) for Glycemic Control and Prevention of Diabetic Foot Ulcer Risk in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusDiabetic Neuropathy
Andina Setyawati 126
Large-scale testing (Phase 3)Study completedNCT00707031
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 639
Testing effectiveness (Phase 2)Study completedNCT01063374
What this trial is testing

Low Glycemic Index Diet for Type 2 Diabetics

Who this might be right for
Type 2 Diabetes
University of Toronto 169
Not applicableStudy completedNCT02065310
What this trial is testing

N2-(1-carboxyethyl)-2'Deoxyguanosine (CEdG) a Potential Biomarker for Diabetes

Who this might be right for
Diabetes
City of Hope Medical Center 26
Not applicableNot Yet RecruitingNCT07302178
What this trial is testing

Combined Bitter Melon Extract and Snakehead Fish Powder Supplementation for Glycemic Control in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Hyperglycemia
Universitas Muhammadiyah Surakarta 80
Not applicableNot Yet RecruitingNCT06684678
What this trial is testing

Individualized Automatic Coaching Message for Glycemic Management and Depressive Symptom

Who this might be right for
Diabetes Mellitus, Type 1Continuous Glucose Measurement
Samsung Medical Center 140
Not applicableStudy completedNCT03781973
What this trial is testing

Bridging the Gap to Adult Diabetes Care

Who this might be right for
Type1diabetes
The Hospital for Sick Children 484
Not applicableEnded earlyNCT03708380
What this trial is testing

Diabetes Prevention for Black Men

Who this might be right for
Diabetes
NYU Langone Health 16
Not applicableStudy completedNCT00676741
What this trial is testing

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 3,809
Post-approval studies (Phase 4)Ended earlyNCT00366301
What this trial is testing

The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Brigham and Women's Hospital 500
Not applicableStudy completedNCT00705952
What this trial is testing

Group Lifestyle Intervention for People With New Onset Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes
The Royal Bournemouth Hospital 22
Testing effectiveness (Phase 2)Study completedNCT02627911
What this trial is testing

Diabeloop WP6.2 : Crossover Evaluation of Glycemic Control

Who this might be right for
Closed LoopDiabetes Mellitus, Type 1
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète 36
Post-approval studies (Phase 4)Ended earlyNCT00437489
What this trial is testing

A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 49
Large-scale testing (Phase 3)Study completedNCT04233801
What this trial is testing

Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 219
Not applicableStudy completedNCT02799953
What this trial is testing

Technology-augmented Self-monitoring Model Among Patients With Type 2 Diabetes and Hypertension

Who this might be right for
Type 2 Diabetes MellitusHypertension
The University of Hong Kong 299
Not applicableStudy completedNCT03812614
What this trial is testing

Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and Support

Who this might be right for
Diabetes MellitusHigh Blood PressureHigh Blood Sugar+1 more
University of Pittsburgh 444
Not applicableStudy completedNCT03388762
What this trial is testing

RCT of a Polyherbal Dietary Supplement for Prediabetes

Who this might be right for
Prediabetic State
University of Maryland, Baltimore 39
Load More Results